Mycenax Biotech Inc. (TPEX:4726)
Taiwan · Delayed Price · Currency is TWD 35.20
-0.55 (-1.54%)
Aug 12, 2025, 1:30 PM CST
Paramount Global Market Cap
Mycenax Biotech has a market cap or net worth of 7.40 billion as of August 11, 2025. Its market cap has decreased by -39.54% in one year.
Market Cap
7.40B
Enterprise Value
8.12B
Revenue
725.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
$35.20
Market Cap Chart
Since October 31, 2008, Mycenax Biotech's market cap has increased from 584.10M to 7.40B, an increase of 1,167.63%. That is a compound annual growth rate of 16.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 7.40B | -17.43% |
| Dec 31, 2024 | 8.97B | 22.00% |
| Dec 29, 2023 | 7.35B | -4.53% |
| Dec 30, 2022 | 7.70B | 32.48% |
| Dec 30, 2021 | 5.81B | 40.74% |
| Dec 31, 2020 | 4.13B | 38.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 203.96B |
| PharmaEssentia | 169.97B |
| Bora Pharmaceuticals Co., LTD. | 88.98B |
| Lotus Pharmaceutical | 57.98B |
| Oneness Biotech | 31.13B |
| Polaris Group | 27.81B |
| Center Laboratories | 27.03B |
| Pegavision | 24.80B |